The Special Clinic for Psoriasis of the Hokkaido University
Department of Dermatology is open on Thursday afternoons.
The patients are mainly those who can benefit from
biologics and oral therapies. The series of anti-IL-23 agents
will start to be released in 2018. Trends in psoriasis treatments
have been steadily changing. Our clinic will have
access to all six biologics that have been authorized as of
January 2018. We can provide a wide range treatment
options to patients who suffer from severe intractable diseases.
We can also introduce such patients to the University
Hospital’s Medical Liaison Center. However, there are many
patients for whom biologics aren’t suitable, for various reasons,
so we’re willing to offer oral therapies such as
cyclosporine and methotrexate. We can accept patients on
hospitalization stays whose purpose is to raise their awareness
of external use of topical agents and the disease. It’s
possible to make appointments directly through the
University Hospital’s Medical Liaison Center. If you encounter
any intractable cases of psoriasis at your institution,
please feel free to consult with our clinic.